Novel upper gastrointestinal bleeding sensor capsule: a first human feasibility and safety trial
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Upper gastrointestinal bleeding (UGIB) is the most common GI condition requiring hospitalization. The present study aimed to evaluate the safety and feasibility of using the PillSense system (EnteraSense Ltd.), a novel diagnostic tool designed for the rapid in vivo detection of UGIB, in human volunteers. Methods: In the present study, 10 volunteers swallowed a PillSense capsule, followed by 2 servings of an autologous blood preparation. Participants were monitored for capsule passage, overall tolerability of the procedure, and adverse events. Results: The procedure was completed per the protocol established in the present study in 9/10 cases. In 9 of the subjects, after capsule ingestion, the device indicated the absence of blood with sensor output values of 1. After the ingestion of the first blood mixture, the sensor outputs of all devices increased to a range from 2.8 to 4, indicating that each sensor capsule detected blood. The sensor output remained within that range after the ingestion of the second mixture; however, in one case, the baseline capsule signal was positive, because of a preexisting condition. The passage of the capsule was verified in all patients, and no adverse events were reported. Conclusions: The first trial of the PillSense system in human subjects demonstrated the feasibility, safety, and tolerability of utilizing this product as a novel, noninvasive, and easy-to-use triage tool for the diagnosis of patients suspected of having UGIB.
Abstract
Background/Aims: Upper gastrointestinal bleeding (UGIB) is the most common GI condition requiring hospitalization. The present study aimed to evaluate the safety and feasibility of using the PillSense system (EnteraSense Ltd.), a novel diagnostic tool designed for the rapid in vivo detection of UGIB, in human volunteers. Methods: In the present study, 10 volunteers swallowed a PillSense capsule, followed by 2 servings of an autologous blood preparation. Participants were monitored for capsule passage, overall tolerability of the procedure, and adverse events. Results: The procedure was completed per the protocol established in the present study in 9/10 cases. In 9 of the subjects, after capsule ingestion, the device indicated the absence of blood with sensor output values of 1. After the ingestion of the first blood mixture, the sensor outputs of all devices increased to a range from 2.8 to 4, indicating that each sensor capsule detected blood. The sensor output remained within that range after the ingestion of the second mixture; however, in one case, the baseline capsule signal was positive, because of a preexisting condition. The passage of the capsule was verified in all patients, and no adverse events were reported. Conclusions: The first trial of the PillSense system in human subjects demonstrated the feasibility, safety, and tolerability of utilizing this product as a novel, noninvasive, and easy-to-use triage tool for the diagnosis of patients suspected of having UGIB.
참고문헌 (21)
- Peery AF, "Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States : update 2021", Gastroenterology, 162, pp.621~644 (2022)
- Oakland K, "Changing epidemiology and etiology of upper and lower gastrointestinal bleeding", Best Pract Res Clin Gastroenterol, 42-43, pp.101610~ (2019)
- Sung JJ, "Towards personalised management for non-variceal upper gastrointestinal bleeding", Gut, 70, pp.818~824 (2021)
- Sengupta N, "Integrating gastrointestinal bleeding risk scores into clinical practice", Am J Gastroenterol, 114, pp.1699~1703 (2019)
- Blatchford O, "A risk score to predict need for treatment for upper-gastrointestinal haemorrhage", Lancet, 356, pp.1318~1321 (2000)
- Saltzman JR, "A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding", Gastrointest Endosc, 74, pp.1215~1224 (2011)
- Rockall TA, "Risk assessment after acute upper gastrointestinal haemorrhage", Gut, 38, pp.316~321 (1996)
- Laine L, "ACG Clinical guideline : upper gastrointestinal and ulcer bleeding", Am J Gastroenterol, 116, pp.899~917 (2021)
- Gralnek IM, "Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage(NVUGIH) : European Society of Gastrointestinal Endoscopy(ESGE)guideline : update 2021", Endoscopy, 53, pp.300~332 (2021)
- Barkun AN, "Management of nonvariceal upper gastrointestinal bleeding", Ann Intern Med, 172, pp.573~ (2020)
- Meltzer AC, "The cost-effectiveness analysis of video capsule endoscopy compared to other strategies to manage acute upper gastrointestinal hemorrhage in the ED", Am J Emerg Med, 32, pp.823~832 (2014)
- Rubin M, "Live view video capsule endoscopy enables risk stratification of patients with acute upper GI bleeding in the emergency room : a pilot study", Dig Dis Sci, 56, pp.786~791 (2011)
- Papaefthymiou A, "Upper gastrointestinal video capsule endoscopy : the state of the art", Clin Res Hepatol Gastroenterol, 46, pp.101798~ (2022)
- Schembre DB, "Semiautomated Glasgow-Blatchford bleeding score helps direct bed placement for patients with upper gastrointestinal bleeding", BMJ Open Gastroenterol, 7, pp.e000479~ (2020)
- ASGE Standards of Practice Committee, "Modifications in endoscopic practice for the elderly", Gastrointest Endosc, 78, pp.1~7 (2013)
- Stolow E, "Management of non-variceal upper GI bleeding in the geriatric population : an update", Curr Gastroenterol Rep, 23, pp.5~ (2021)
- Ahmed A, "Upper gastrointestinal bleeding in Scotland 2000-2010 : improved outcomes but a significant weekend effect", World J Gastroenterol, 21, pp.10890~10897 (2015)
- Gupta A, ""Weekend effect"in patients with upper gastrointestinal hemorrhage : a systematic review and meta-analysis", Am J Gastroenterol, 113, pp.13~21 (2018)
- Forbes N, "Development and validation of a patient-reported scale for tolerability of endoscopic procedures using conscious sedation", Gastrointest Endosc, 94, pp.103~110 (2021)
- Wilcox CM, "A prospective characterization of upper gastrointestinal hemorrhage presenting with hematochezia", Am J Gastroenterol, 92, pp.231~235 (1997)
- Al Hillan A, "Capsule endoscopy transit time to duodenum : relation to patient demographics", Cureus, 12, pp.e6894~ (2020)